Evaluation of the Pharmacokinetics and Safety/Tolerability of Avanafil, a Novel Phosphodiesterase Type 5 Inhibitor in Healthy Korean Subjects

  • Jung, J.A. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Choe, S.M. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Cho, S.H. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Ghim, J.L. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Kim, U.J. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Lim, H.S. (Clinical Pharmacology & Therapeutics, Asan Medical Center) ;
  • Bae, K.S. (Clinical Pharmacology & Therapeutics, Asan Medical Center)
  • Published : 2007.11.08

Abstract

See Full Text

Keywords